Parkinson disease gene therapy moves toward the clinic
- 1 November 2000
- journal article
- editorial
- Published by Springer Nature in Nature Medicine
- Vol. 6 (11), 1207-1208
- https://doi.org/10.1038/81291
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Neurodegeneration Prevented by Lentiviral Vector Delivery of GDNF in Primate Models of Parkinson's DiseaseScience, 2000
- Long-Term rAAV-Mediated Gene Transfer of GDNF in the Rat Parkinson's Model: Intrastriatal But Not Intranigral Transduction Promotes Functional Regeneration in the Lesioned Nigrostriatal SystemJournal of Neuroscience, 2000
- In Vivo Protection of Nigral Dopamine Neurons by Lentiviral Gene Transfer of the Novel GDNF-Family Member Neublastin/ArteminMolecular and Cellular Neuroscience, 2000
- Lentiviral vectors: turning a deadly foe into a therapeutic agentGene Therapy, 2000
- Self-Inactivating Lentiviral Vectors with Enhanced Transgene Expression as Potential Gene Transfer System in Parkinson's DiseaseHuman Gene Therapy, 2000
- Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's diseaseAnnals of Neurology, 1999
- Neuroprotective and neurorestorative properties of GDNFAnnals of Neurology, 1998
- Dopaminergic Neurons Protected from Degeneration by GDNF Gene TherapyScience, 1997
- Studies on Neuroprotective and Regenerative Effects of GDNF in a Partial Lesion Model of Parkinson's DiseaseNeurobiology of Disease, 1997
- GDNF: a Glial Cell Line-Derived Neurotrophic Factor for Midbrain Dopaminergic NeuronsScience, 1993